iShares iBoxx $ High Yield Corporate Bond ETF vs Lemonade Inc — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.23 (market cap $17.89B), while Lemonade Inc trades at $46.47 (market cap $3.63B). The key difference: iShares iBoxx $ High Yield Corporate Bond ETF is far larger — about 4.9× Lemonade Inc's market cap, and iShares iBoxx $ High Yield Corporate Bond ETF is more actively traded (44,866,592 versus 1,544,794). Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ High Yield Corporate Bond ETF for 60 Days and Lemonade Inc for 27 Days on average.
| HYG | LMND | |
|---|---|---|
Market Cap | $17.89B | $3.63B |
Volume | 44,866,592 | 1,544,794 |
Sector | Fixed Income | Financials |
52-Week High | $81.28 | $96.57 |
52-Week Low | $76.90 | $43.91 |
Typical Hold Time | 60 Days | 27 Days |
Enterprise Value | — | $3.49B |
Signals from Pluang's Aura AI — not financial advice
HYG trades at $77.205, showing minimal daily movement with a 0.03% gain. Technical indicators signal a bearish trend with moving averages and ADX pointing downward, though RSI suggests potential oversold conditions. The ETF maintains regular dividend distributions, with recent payouts ranging from $0.38 to $0.44. Market focus remains on high-yield bond performance amid rising Treasury yields and Federal Reserve policy uncertainty.
The outlook for HYG remains challenged by persistent bond market volatility and rising interest rates. While the fund's consistent dividend payments provide income support, the bearish technical setup and macroeconomic headwinds suggest continued pressure on high-yield corporate bonds. Investors face risks from credit quality deterioration and duration exposure in a rising rate environment.
LMND trades at $46.64, down 0.41% on the day, with a bearish technical signal despite recent earnings beats. Revenue growth remains strong at 32% year-over-year in Q2 2026, with improving loss ratios and gross profit up 76%. The company is expanding geographically and expects its first EBITDA-positive quarter in late 2026, supported by AI-driven efficiency gains.
While LMND shows promising growth and path to profitability, the stock faces headwinds from persistent net losses, high valuation multiples, and mixed analyst sentiment. The consensus price target of $67.00 suggests 44% upside potential, but investors must weigh growth prospects against ongoing cash burn and competitive pressures in the insurtech space.
Trailing returns across standard periods
Latest headlines on both assets
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →